Spain Blood Collection Devices Market (2025-2030)
The Spain Blood Collection Devices Market was valued at $69.7 Million in 2025 and projected to reach to $95.9 Million by 2030, representing a compound annual growth rate of 6.6%. Spain's blood collection devices market is positioned for steady growth through 2030, supported by the country's advanced healthcare infrastructure and increasing emphasis on diagnostic accuracy.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Spain Blood Collection Devices Market Trends and Insights
- Spain's healthcare infrastructure and increasing demand for diagnostic testing are driving adoption of advanced blood collection technologies across hospitals, clinics, and blood banks.
- The Spanish market benefits from strong regulatory frameworks and rising awareness of infection control and patient safety standards. During the 2025–2030 forecast period, Spain is expected to experience steady growth in blood collection device adoption, supported by aging demographics and higher prevalence of chronic diseases requiring routine blood work.
- Spain's investment in healthcare modernization and laboratory automation is accelerating the transition from conventional to safety-engineered devices.
- Market expansion in Spain is also fueled by increased blood donation campaigns and improved accessibility to diagnostic services across both urban and rural regions..
Key Market Statistics
- CAGR (2025-2030) 6.6% CAGR
- Market Size, 2025 ~USD 69.7 Million
- Forecast, 2030 ~USD 95.9 Million
- Country Spain
Spain Blood Collection Devices Market Overview
Market Valuation :
Spain's blood collection devices market is valued at USD 69.7 million in 2025, with projected growth to USD 95.9 million by 2030, reflecting strong healthcare investment and diagnostic demand.
Growth Trajectory :
The Spanish market is expanding at a CAGR of 6.6% through 2030, driven by modernization of healthcare facilities and increased prevalence of chronic diseases requiring regular blood testing.
Healthcare Infrastructure :
Spain's robust public healthcare system and well-established network of hospitals, clinics, and blood banks are accelerating adoption of advanced blood collection technologies and safety-engineered devices.
Diagnostic Testing Demand :
Rising demand for preventive healthcare and diagnostic testing across Spain's aging population is fueling procurement of innovative blood collection solutions in both primary and secondary care settings.
Spain Blood Collection Devices Market Dynamics
- The Spanish healthcare system's commitment to modernization and patient safety standards is driving adoption of safety-engineered needles, vacuum tubes, and automated collection systems.
- Healthcare providers are investing in technologies that reduce needlestick injuries and improve sample quality, aligning with EU regulatory requirements and best practices.
- The aging Spanish population and rising prevalence of chronic conditions requiring regular monitoring will continue to sustain demand for blood collection devices across hospitals, outpatient clinics, and specialized blood collection centers throughout the forecast period..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Spain's blood collection devices market is valued at USD 69.7 million in 2025 and will grow to USD 95.9 million by 2030 at a 6.6% CAGR.
- Spain's aging population and rising chronic disease prevalence are key drivers of increased diagnostic testing and blood collection device demand.
- Safety-engineered and automated blood collection technologies are gaining traction in Spain due to stringent occupational safety regulations.
- Spain's healthcare modernization initiatives and laboratory automation investments are accelerating market growth through 2030.
Blood Collection Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PLASMA/WHOLE BLOOD TUBES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.4% from 2025 to 2030 |
| Largest Segment | MANUAL BLOOD COLLECTION (Method) |
| Market Size Base Year (Billions) | ~USD 9.11 (2025) |
| Revenue Forecast (Billions) | ~USD 13.02 (2030) |
| Segments Covered | Product, Type, System Type, Method, Application, End User |
Spain Blood Collection Devices Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Blood Bags
- Blood Collection Systems/ Monitors
- Blood Collection Tubes
- Lancets
- Needle & Syringes
By Type
- Coagulation Tubes
- Edta Tubes
- Esr Tubes
- Glucose Tubes
- Heparin Tubes
- Plasma/Whole Blood Tubes
- Serum Tubes
By System Type
- Non-Vacuum Type
- Vacuum Type
By Method
- Automated Blood Collection
- Manual Blood Collection
By Application
- Diagnostic Applications
- Therapeutic Applications
By End User
- Blood Banks
- Diagnostic & Pathology Labs
- Hospitals, Ambulatory Surgical Centers, And Nursing Homes
- Other End Users
SPAIN: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| BLOOD BANKS | 33.8 | 35.2 | 36.3 | 37.6 | 39.2 | 41 | 43.1 | 45.4 | 4.6 |
| DIAGNOSTIC & PATHOLOGY LABS | 45.5 | 48.1 | 50.3 | 52.9 | 55.9 | 59.4 | 63.2 | 67.6 | 6.1 |
| HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES | 108.7 | 115.8 | 122.3 | 129.6 | 138 | 147.6 | 158.4 | 170.6 | 6.9 |
| OTHER END USERS | 12.4 | 12.8 | 13.2 | 13.6 | 14.1 | 14.7 | 15.3 | 16.1 | 4.1 |
| TOTAL | 200.3 | 211.8 | 222.1 | 233.7 | 247.3 | 262.7 | 280 | 299.7 | 6.2 |
Target Audience
- Medical Device Manufacturers : Manufacturers need Spain-specific market data to assess market entry feasibility, competitive positioning, and revenue potential for blood collection device portfolios in the Spanish healthcare market.
- Healthcare Procurement Officers : Hospital and clinic procurement teams require market insights to benchmark pricing, evaluate supplier options, and make informed purchasing decisions for blood collection devices aligned with budget constraints.
- Investment & Private Equity Firms : Investors evaluating healthcare sector opportunities in Spain need detailed market analysis to assess growth potential, identify acquisition targets, and determine investment returns in blood collection device companies.
- Healthcare Consultants : Consulting firms advising Spanish healthcare providers and medical device companies require market intelligence to develop strategic recommendations and optimize operational efficiency in blood collection services.
- Regulatory & Compliance Specialists : Regulatory professionals need Spain-specific market data and compliance requirements to navigate EU regulations, ensure product certification, and support market authorization strategies for blood collection devices.
Key Companies in the Spain Blood Collection Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula), |
| NOLATO | Sweden | Public Company | Medical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC), |
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables), |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components), |
| HAEMONETICS CORPORATION | United States | Public Company | Plasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware, |
| CARDINAL HEALTH | United States | Public Company | Branded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands), |
| RETRACTABLE TECHNOLOGIES, INC. | United States | Public Company | VanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps, |
| AB MEDICAL CO., LTD. | Ireland | Public Company | Cardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ABBOTT LABORATORIES
Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.
QIAGEN NV
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.
DANAHER CORPORATION
Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.
GRIFOLS, S.A.
Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.
NIPRO CORPORATION
Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.
HAEMONETICS CORPORATION
Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.
ICU MEDICAL, INC.
ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.
CARDINAL HEALTH
Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.
RETRACTABLE TECHNOLOGIES, INC.
Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.
AB MEDICAL CO., LTD.
AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.
Reasons to Buy this Report
- Market-Specific Sizing : Obtain precise valuation data for Spain's blood collection devices market with verified 2025 baseline (USD 69.7M) and 2030 forecast (USD 95.9M), enabling accurate budget allocation and revenue projections.
- Competitive Landscape Intelligence : Understand Spain-specific competitive dynamics, key market players, and their positioning within the Spanish healthcare system to identify partnership and expansion opportunities.
- Regulatory & Compliance Insights : Access Spain-specific regulatory requirements, EU compliance standards, and healthcare procurement processes essential for market entry and product commercialization strategies.
- Growth Driver Analysis : Identify Spain-specific growth catalysts including healthcare infrastructure investments, aging population demographics, and diagnostic testing trends to inform strategic planning.
- Localized Market Strategy : Develop targeted go-to-market strategies tailored to Spain's healthcare system structure, reimbursement models, and customer preferences for blood collection device procurement.
Frequently asked questions
What is the current size of Spain's blood collection devices market?
Spain's blood collection devices market is valued at USD 69.7 million in 2025.
What is the projected market size for Spain by 2030?
Spain's blood collection devices market is projected to reach USD 95.9 million by 2030.
What is the CAGR for Spain's blood collection devices market?
Spain's blood collection devices market is expected to grow at a compound annual growth rate of 6.6% from 2025 to 2030.
What factors are driving growth in Spain's blood collection devices market?
Key growth drivers in Spain include an aging population, rising chronic disease prevalence, healthcare modernization, laboratory automation, and increased emphasis on infection control and patient safety.
Which blood collection device types are most in demand in Spain?
Safety-engineered and automated blood collection devices are experiencing the highest demand in Spain due to occupational safety regulations and healthcare facility modernization efforts.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.
Stakeholders
- Healthcare Service Providers (Hospitals and Pathology Centers)
- Blood Collection Product Manufacturers
- Blood Banks
- Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market
Get the Full Blood Collection Devices Market Report
Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.
- China Blood Collection Devices Market
- India Blood Collection Devices Market
- Australia Blood Collection Devices Market
- Rest Of Europe Blood Collection Devices Market
- Rest Of Asia Pacific Blood Collection Devices Market
- Canada Blood Collection Devices Market
- US Blood Collection Devices Market
- Germany Blood Collection Devices Market
- France Blood Collection Devices Market
- UK Blood Collection Devices Market
- Italy Blood Collection Devices Market
- Japan Blood Collection Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
